PharmaVOICE - 
February 2011
Purchase Issue

In Every Issue
Last Word
PV: What should the goals of a corporate social media [...]
By
Talent Pool
Pharmaceutical POOL Robert DAVIS Dr. Ludwig HANTSON Baxter International Forms [...]
By
Social Media
Pharma is Using Social Media, With Reservations Trend Watch: More [...]
By
Tools of the Trade
New Platforms Streamline Scientific Data Sharing Trends: Service providers are [...]
By
What’s New
Trend: As the healthcare industry continues to consolidate and rationalize, [...]
By
PharmaTrax
Trend: With its traditional business model breaking down amid scant [...]
By
UpFront
Awards… Cephalon wins PRSA Awards CRF Health Wins at Clio [...]
By
Letter from the Editor
Pharma 3.0: Are you ready? The era of Pharma 3.0 [...]
By

Taren Grom, Editor

On The Cover

Developing A True Strategic Partnership
The biopharmaceutical industry is facing intense pressure within research and development to bring new drugs to the market at a time when drug development has become complex and expensive. Blockbuster patent expirations, more complex protocols, increasing R&D costs, patient recruitment issues, and more stringent regulatory and safety issues are all challenging drug developers. As a [...]
By

Denise Myshko

Features

The Push and Pull of Patient Recruitment
There are two sides to patient recruitment: the “push” (advertising) and the “pull” (referral management to randomization). While many companies focus a lot of effort on the push side of recruitment, the importance of the pull can often be overlooked. Yet this is where the rubber meets the road. The push encourages people to take [...]
By

Liz Moench, President & CEO, MediciGlobal

Achieving More Precise Patient Recruitment
While pharmaceutical market researchers have benefited from comprehensive, secondary data sources and sophisticated analytics for years, the R&D functions and clinical research organizations (CROs) were on the outside looking in when it came to access to this information and analytical approach. However, today R&D pharma executives and CROs can tap into these rich data resources [...]
By

Michel Denarié and Robert Kraft, IMS Health

Global Patient Recruitment: Preventing Delays Through Knowledge Application
Enrollment of clinical trial subjects in far-ranging global destinations has become desirable for many drug developers. Generally, these regions offer a large pool of relatively treatment-naïve patients, GCP-standard medical facilities, capable health care professionals and a substantially lower cost to conduct clinical studies. The varying regulatory and ethical requirements, complicated by medical, cultural and political [...]
By

Sandra Chase, VP Operations, Healthcare Communications Group

SHOWCASE FEATURE: Unclogging the Patient Recruitment Bottleneck
The increased complexity of clinical trial design and the trend toward more targeted patient populations necessitates rethinking the traditional methods of patient recruitment to ­overcome failure and timeline extensions. Patient recruitment remains to be one of the biggest, and most costly, bottlenecks in clinical development. While the most commonly accepted recruitment mainstays are investigative site [...]
By

Taren Grom, Editor

Emerging Market: China
Whether it is partnering, acquisitions, or the expansion of operations, China spells opportunity for the pharmaceutical industry. Increasingly, global pharmaceutical companies are either expanding their own operations within China or choosing to partner with China-based companies. According to IMS Health, China is expected to become the world’s third-largest prescription drug market in 2011 and the [...]
By

Kim Ribbink

M&A: A Short-Term Solution Whose Time May Be Over
2009 was punctuated by the latest and greatest round of major pharmaceutical company mergers, with the big three — Merck and Schering-Plough, Pfizer and Wyeth, and Roche and Genentech — shining a spotlight on M&A practices in the industry. In reality, M&A has always been a growth strategy for life-sciences companies, enabling them to add [...]
By

Robin Robinson

Digital Marketing: Dare to be Different
Research shows creativity is one of the most important components of a successful campaign, however, our experts say there are several other elements behind a campaign that need to be present to make the best of what digital media have to offer. Among them are matching the audience with the most appropriate channel and thoroughly [...]
By

Robin Robinson

The Era of Proactive Safety
Process, people, and technology have to align to ­enable a truly proactive risk-management and ­pharmacovigilance program that protects patients. First, do no harm. This is medicine’s highest ethical standard, an oath physicians take when they begin to practice. In the last few years, dangerous side effects of blockbuster products and some high-profile product withdrawals have [...]
By

Denise Myshko

FEEDBACK